Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
01/2008
01/22/2008US7321063 Sulfonamide inhibitors of aspartyl protease
01/22/2008US7321044 Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens
01/22/2008US7321043 Processes for the preparation of 2-aminomethylpyridines and the 2-cyanopyridines used in their preparation
01/22/2008US7321001 carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer
01/22/2008US7320993 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents
01/22/2008US7320983 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
01/22/2008US7320979 Diseases which respond to influencing by dopamine D3 receptor antagonists or agonists, diseases of the central nervous system and disturbances of kidney function; N-[6-(4-Allylpiperazin-1-yl)pyridin-3-yl]-4-isopropylbenzenesulfonamide
01/22/2008US7320833 Electroluminescent platinum compounds and devices made with such compounds
01/22/2008CA2420999C 2-substituted heterocyclic compounds and their use in treating multidrug resistance
01/22/2008CA2392168C Vitamin d analogues
01/22/2008CA2374362C Urea derivatives as hiv aspartyl protease inhibitors
01/22/2008CA2199669C Halogenation catalyst
01/22/2008CA2177651C Microbiological process for the preparation of heteroaromatic carboxylic acids using microorganisms of the genus alcaligenes
01/17/2008WO2008008954A2 Isothiocyanates and glucosinolate compounds and anti-tumor compositios containing same
01/17/2008WO2008008718A2 Cyclopentane derivatives as antiglaucoma agents
01/17/2008WO2008008660A2 Cyclopentane derivatives as antiglaucoma agents
01/17/2008WO2008008059A1 Anti-cancer agents ans uses thereof
01/17/2008WO2008007780A1 Pentadienamide derivative
01/17/2008WO2008007117A1 Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate
01/17/2008WO2008006509A1 Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors
01/17/2008WO2008006481A1 Vr1 vanilloid receptor antagonists with a iononic substructure
01/17/2008WO2008006478A1 Method for the production of 6-(aminocarbonyl) nicotinic acid butyl ester, and use thereof for the production of 5-formylpyridine-2-carbonitrile
01/17/2008WO2007113202A8 Piperazine derivatives as growth hormone secretagogue (ghs) receptor agonists
01/17/2008WO2007096647A3 Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer
01/17/2008WO2007080159A3 Pyridine-, isoxazole, thiophenecarboxamide compounds having activity at the glycine transporter glyt1 and uses thereof
01/17/2008US20080015230 Heterocyclic derivatives and their use as therapeutic agents
01/17/2008US20080015209 Compounds for the treatment of metabolic disorders
01/17/2008US20080015195 Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
01/17/2008US20080015193 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof
01/17/2008US20080015191 Pyrazines and Pyridines and Derivatives Thereof as Therapeutic Compounds
01/17/2008US20080015185 N-heterocyclic inhibitors of tnf-alpha expression
01/17/2008US20080015180 Methods and compositions for treating amyloid-related diseases
01/17/2008US20080015169 Amino-methyl substituted tetracycline compounds
01/17/2008DE102006032589A1 Verfahren zur Herstellung von 5-Formylpyridin-2-carbonitril A process for the preparation of 5-formylpyridine-2-carbonitrile
01/17/2008CA2659121A1 Therapeutic compounds
01/17/2008CA2658097A1 Pentadienamide derivatives
01/17/2008CA2657719A1 Cyclopentane derivatives as antiglaucoma agents
01/17/2008CA2657541A1 Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate
01/17/2008CA2657304A1 Vr1 vanilloid receptor antagonists with a iononic substructure
01/16/2008EP1877495A2 Reactive azo dyes, methods for the production thereof and their use
01/16/2008EP1877382A2 Improved chemical identification of peroxide-based explosives
01/16/2008EP1877381A1 Pyridines useful as modulators of ion channels
01/16/2008EP1877380A1 Sulfonylamino(thio)carbonyl compounds in the form of herbicides or plant growth regulators
01/16/2008EP1877377A2 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
01/16/2008EP1877367A1 Acetylene derivatives
01/16/2008EP1877364A1 Phenylacetylene derivatives having mglur5 receptor affinity
01/16/2008EP1687288B1 Substituted aryl cycloalkanol derivatives and methods of their use
01/16/2008EP1644320B1 Indane derivates as muscarinic receptor agonists
01/16/2008EP1567486B1 Bis-aryl sulfonamides
01/16/2008EP1458684B1 Therapeutic heterocycles as bradykinin b2 receptor antagonists
01/16/2008EP1122242B1 Cyanophenyl derivatives
01/16/2008CN101107230A Process for production of 5-chloro-2,4-dihydroxypyridine
01/16/2008CN101107226A Phenoxyacetic acid derivatives useful for treating respiratory diseases
01/16/2008CN101104598A Process for preparing trans-4-amino-1-cyclohexanecarboxilic acid derivatives
01/16/2008CN100361997C Salts comprising cyanoborate anions
01/16/2008CN100361943C 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxypyridin-3-yl)propyl] benzamide, its use as a medicament, and pharmaceutical preparations comprising it
01/15/2008US7319163 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism
01/15/2008US7319149 Chelants and macrocyclic metal complex radiopharmaceuticals thereof
01/15/2008US7319111 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists
01/15/2008US7319104 hPPARs activators
01/15/2008US7319099 Benzoyl-piperazine derivatives
01/15/2008US7319096 Antiarrhythmia agents; liver disorders; skin disorders
01/15/2008US7318966 Luminescent element material and luminescent element comprising the same
01/15/2008CA2265666C Cytostatic hydroxamic acid derivatives
01/10/2008WO2008005954A2 Tryphostin-analogs for the treatment of cell proliferative diseases
01/10/2008WO2008004943A1 New pyridine analogues
01/10/2008WO2008004836A1 Triazine derivative compound and composition for treating cancer containing them
01/10/2008WO2008003745A1 N- (4-pyridin-2-ylbutyl) benzamide derivatives and their use as fungicides
01/10/2008WO2008003744A2 N-methyl benzamide derivatives useful as fungicides
01/10/2008WO2008003741A1 N- [ (pyridin- 2 -yl) methoxy]heterocyclyl carboxamide derivatives and related compounds as fungicides
01/10/2008WO2008003739A1 N-[(pyridin-2-yl) methoxy]benzamide derivatives and related compounds as fungicides
01/10/2008WO2008003141A1 Therapeutic compounds
01/10/2008WO2007137107A3 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
01/10/2008WO2007136572A3 Antidiabetic bicyclic compounds
01/10/2008US20080009633 Method for Producing High-Purity Quaternary Ammonium Compounds
01/10/2008US20080009530 Therapeutic Agent for Diabetes
01/10/2008US20080009528 such as 4-(2,4-dichlorophenyl)-6-(3-hydroxyphenyl)-2-methyl-3-cyanopyridine, used for inhibiting growth of Gram-positive bacteria selected from Bacillus, Listeria, Staphylococcus, Streptococcus, Enterococcus, Corynebacterium, Propionibacterium and Clostridium
01/10/2008US20080009498 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use
01/10/2008US20080009494 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses
01/10/2008US20080007161 Compound for organic el device and light-emitting device
01/10/2008CA2656929A1 Triazine derivative compound and composition for treating cancer containing them
01/10/2008CA2656851A1 Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity
01/10/2008CA2656597A1 New pyridine analogues
01/09/2008EP1874746A2 Novel histamine h3-receptor ligands and their therapeutic applications
01/09/2008EP1874724A2 Phenyl ethyne compounds
01/09/2008EP1663936B1 Biaryloxymethylarene-carboxylic acids
01/09/2008EP1402890B1 Sulfonamide derivatives
01/09/2008EP1400513B1 Unsymmetrical cyclic diamine compound
01/09/2008EP1296952B9 Benzoylpyridine derivative or its salt, fungicide containing it as an active ingredient, its production process and intermediate for producing it
01/09/2008EP1176956B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
01/09/2008EP1129064B1 Transfection reagents
01/09/2008CN101103000A Carbazole, carboline, and indole derivatives useful in the inhibition of VEGF production
01/09/2008CN101102843A Methods for producing a hexadentate bimetallic complex
01/09/2008CN101100454A Method for preparing 2-bromo-3-ethylsulfonylpyridine
01/09/2008CN100360709C Volatile copper(II) complexes for deposition of copper films by atomic layer deposition
01/09/2008CN100360526C Aryl sulfonamides
01/09/2008CN100360499C Propanoic acid derivatives that inhibit binding of integrins to their receptors
01/08/2008US7317112 Catalysts for selective isocyanate dimerization
01/08/2008US7317105 Preparation of 4-haloalkylnicotinamides
01/08/2008US7317057 Transition metal complex of an iminated pyridine with an anionic monodentate ligand ({2-acetyl(2,6-diisopropylanil)-6-phenyl(2'-methoxy)-pyridine}FeCl2); olefin polymerization catalysts